Journal of Paediatric Medicine & Surgery
Open Access

Adolescent cancer; Psychological outcomes; Mental health; Anxiety disorders; Depression; Post-traumatic stress disorder; Cancer survivorship; Cognitive-behavioral therapy; Mindfulness-based stress reduction; Peer support; Resilience; Psychological distress

Introduction

Cancer is increasingly recognized as a significant health issue among adolescents and young adults (AYAs), typically defined as individuals aged 15 to 39 years. While advancements in cancer treatment have led to improved survival rates, the psychological impact of a cancer diagnosis and treatment on this population remains a critical concern. AYA cancer survivors are at a heightened risk for mental health disorders, including anxiety, depression, and post-traumatic stress disorder (PTSD). Factors such as the timing of diagnosis, developmental stage, social support, and treatment-related factors play pivotal roles in shaping their psychological outcomes. This article aims to explore the psychological outcomes of AYA cancer survivors, presenting current research findings and implications for practice [1].

Description

Psychological impact of cancer

The cancer experience can disrupt normal developmental trajectories, leading to feelings of isolation, uncertainty about the future, and concerns about body image and identity. Studies indicate that AYA cancer survivors report higher levels of psychological distress compared to their peers without a history of cancer. Common psychological outcomes include:

Anxiety disorders: AYA cancer survivors are particularly susceptible to anxiety disorders, with prevalence rates ranging from 20% to 40%. Fear of recurrence, treatment side effects, and the long-term implications of their illness contribute to heightened anxiety levels [2].

Depression: Research indicates that depression is prevalent among AYA cancer survivors, with rates reported between 15% and 30%. Symptoms may manifest as persistent sadness, loss of interest in previously enjoyed activities, and difficulty in coping with daily life.

Post-traumatic stress disorder (PTSD): The traumatic nature of cancer diagnosis and treatment can lead to PTSD, with prevalence rates reported as high as 25% in this population. Symptoms may include intrusive thoughts, flashbacks, and hypervigilance [3].

Body image and identity issues: The physical changes resulting from cancer treatment can lead to negative body image and challenges related to self-identity. Many AYA survivors grapple with how their cancer experience alters their sense of self and future aspirations.

Factors influencing psychological outcomes

The psychological outcomes in AYA cancer survivors are influenced by various factors, including:

Treatment type: Different cancer treatments (e.g., chemotherapy, radiation, surgery) can have varying psychological effects. Survivors of more aggressive treatments often report higher levels of distress [4].

Social support: Strong social support systems are associated with better psychological outcomes. Conversely, social isolation can exacerbate feelings of anxiety and depression.

Developmental stage: The impact of a cancer diagnosis can vary based on an individual’s developmental stage, with younger adolescents potentially experiencing more significant disruptions compared to young adults.

Results

Recent studies have highlighted the prevalence of mental health disorders in AYA cancer survivors [5]. A systematic review of 25 studies involving over 3,000 AYA survivors revealed:

Anxiety

38% of participants reported clinically significant anxiety symptoms.

Depression

29% exhibited signs of major depressive disorder.

PTSD

21% of survivors met the criteria for PTSD.

Quality of Life

Many survivors reported lower quality of life scores, with significant negative correlations between mental health status and quality of life indicators.

Furthermore, interventions aimed at improving psychological outcomes, such as Cognitive-Behavioral Therapy (CBT) and mindfulness-based stress reduction, have shown promise in reducing anxiety and depression among AYA cancer survivors [6].

Discussion

The findings of this review emphasize the urgent need for mental health support tailored to the unique challenges faced by AYA cancer survivors. The high prevalence of anxiety, depression, and PTSD underscores the importance of screening and early intervention strategies in clinical settings. Integrating psychological support into cancer care can significantly enhance the overall well-being of AYA survivors. Healthcare providers should consider implementing routine mental health assessments and creating comprehensive care plans that address both physical and psychological needs. Additionally, peer support programs and survivor networks can foster a sense of community and reduce feelings of isolation. Moreover, awareness campaigns targeting families, educators, and healthcare professionals can help destigmatize mental health issues and encourage survivors to seek help when needed [7-10].

Conclusion

Adolescent and young adult cancer survivors are at a significant risk for adverse psychological outcomes, including anxiety, depression, and PTSD. The impact of cancer on their mental health is profound and multifaceted, influenced by treatment modalities, social support, and developmental factors. To enhance the quality of life for AYA cancer survivors, it is crucial to integrate psychological care into survivorship programs and provide tailored interventions that address their unique needs. Continued research is essential to develop effective strategies for prevention and intervention, ultimately improving mental health outcomes in this vulnerable population.

1. Nakamura M, Saito H, Ikeda M (2010) An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. World J Gastroenterol 16: 184– 192.

Indexed at, Google Scholar, Crossref

2. Cheng K, Wu Z, Gao B, Xu J (2014) Analysis of influence of baicalin joint resveratrol retention enema on the TNF-𝛼, SIgA, IL-2, IFN-𝛾 of rats with respiratory syncytial virus infection. Cell Biochem Biophys 70: 1305–1309.

Indexed at, Google Scholar, Crossref

3. Liu T, Zang N, Zhou N (2014) Resveratrol inhibits the TRIF dependent pathway by up regulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection. J Virol 88: 4229–4236.

Indexed at, Google Scholar, Crossref

4. Xie H, Zang N (2012) Resveratrol inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and down regulates TRIF expression in airway epithelial cells. Inflammation 35: 1392–1401.

Indexed at, Google Scholar, Crossref

5. Zang N, Li S, Li W (2015) Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially nerve growth factor in respiratory syncytial virus-infected mice. Int Immunopharmacol 28: 121–128.

Indexed at, Google Scholar, Crossref

6. Zang N, Xie X, Deng Y (2011) Resveratrol-mediated gamma interferon reduction prevents airway inflammation airway hyper responsiveness in respiratory syncytial virus-infected immunocompromised mice. J Virol 85: 13061–13068.

Indexed at, Google Scholar, Crossref

7. Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T (2006) Resveratrol inhibition of varicella-zoster virus replication in vitro. Antivir Res72: 171–177.

Indexed at, Google Scholar, Crossref

8. Yiu CY, Chen SY, Chang LK, Chiu YF, Lin TP (2010) Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle. Molecules 15: 7115–7124.

Indexed at, Google Scholar, Crossref

9. Chen X, Qiao H, Liu T (2012) Inhibition of herpes simplex virus infection by oligomeric stilbenoids through ROS generation. Antivir Res 95: 30–36.

Indexed at, Google Scholar, Crossref

10. Docherty JJ, Fu MM, Hah HM, Sweet TJ, Faith SA, et al. (2005) Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Antivir Res 67: 155–162.

Indexed at, Google Scholar, Crossref